nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—Tonsillitis—Metformin—metabolic syndrome X	0.0263	0.0781	CcSEcCtD
Lansoprazole—Abnormal faeces—Metformin—metabolic syndrome X	0.0232	0.069	CcSEcCtD
Lansoprazole—Epigastric discomfort—Metformin—metabolic syndrome X	0.0126	0.0375	CcSEcCtD
Lansoprazole—ATP4B—liver—metabolic syndrome X	0.0106	0.109	CbGeAlD
Lansoprazole—Nail disorder—Metformin—metabolic syndrome X	0.0102	0.0304	CcSEcCtD
Lansoprazole—CYP4A11—kidney—metabolic syndrome X	0.00902	0.0931	CbGeAlD
Lansoprazole—MAPT—adipose tissue—metabolic syndrome X	0.00882	0.0911	CbGeAlD
Lansoprazole—Blood disorder—Metformin—metabolic syndrome X	0.00794	0.0236	CcSEcCtD
Lansoprazole—Contusion—Metformin—metabolic syndrome X	0.0076	0.0226	CcSEcCtD
Lansoprazole—Accidental injury—Metformin—metabolic syndrome X	0.0075	0.0223	CcSEcCtD
Lansoprazole—ATP4A—cardiovascular system—metabolic syndrome X	0.00743	0.0767	CbGeAlD
Lansoprazole—ATP4A—kidney—metabolic syndrome X	0.00727	0.0751	CbGeAlD
Lansoprazole—Neuropathy—Metformin—metabolic syndrome X	0.00623	0.0185	CcSEcCtD
Lansoprazole—CYP4A11—liver—metabolic syndrome X	0.0057	0.0589	CbGeAlD
Lansoprazole—Ear pain—Metformin—metabolic syndrome X	0.00564	0.0168	CcSEcCtD
Lansoprazole—Injury—Metformin—metabolic syndrome X	0.00524	0.0156	CcSEcCtD
Lansoprazole—Renal impairment—Metformin—metabolic syndrome X	0.00506	0.015	CcSEcCtD
Lansoprazole—Hypoglycaemia—Metformin—metabolic syndrome X	0.00493	0.0147	CcSEcCtD
Lansoprazole—Migraine—Metformin—metabolic syndrome X	0.00474	0.0141	CcSEcCtD
Lansoprazole—ATP4A—liver—metabolic syndrome X	0.00459	0.0475	CbGeAlD
Lansoprazole—Dehydration—Metformin—metabolic syndrome X	0.00448	0.0133	CcSEcCtD
Lansoprazole—Liver function test abnormal—Metformin—metabolic syndrome X	0.00445	0.0132	CcSEcCtD
Lansoprazole—Breast disorder—Metformin—metabolic syndrome X	0.00435	0.0129	CcSEcCtD
Lansoprazole—Cramp muscle—Metformin—metabolic syndrome X	0.00434	0.0129	CcSEcCtD
Lansoprazole—Nasopharyngitis—Metformin—metabolic syndrome X	0.00431	0.0128	CcSEcCtD
Lansoprazole—Abdominal distension—Metformin—metabolic syndrome X	0.00419	0.0125	CcSEcCtD
Lansoprazole—Influenza—Metformin—metabolic syndrome X	0.00416	0.0124	CcSEcCtD
Lansoprazole—Pancreatitis—Metformin—metabolic syndrome X	0.00408	0.0121	CcSEcCtD
Lansoprazole—Angina pectoris—Metformin—metabolic syndrome X	0.00405	0.0121	CcSEcCtD
Lansoprazole—Abdominal discomfort—Metformin—metabolic syndrome X	0.00399	0.0119	CcSEcCtD
Lansoprazole—Neutropenia—Metformin—metabolic syndrome X	0.00389	0.0116	CcSEcCtD
Lansoprazole—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00387	0.0115	CcSEcCtD
Lansoprazole—CYP2C18—liver—metabolic syndrome X	0.00378	0.039	CbGeAlD
Lansoprazole—Infestation NOS—Metformin—metabolic syndrome X	0.00371	0.011	CcSEcCtD
Lansoprazole—Infestation—Metformin—metabolic syndrome X	0.00371	0.011	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00364	0.0108	CcSEcCtD
Lansoprazole—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00351	0.0104	CcSEcCtD
Lansoprazole—Bradycardia—Metformin—metabolic syndrome X	0.00339	0.0101	CcSEcCtD
Lansoprazole—Rhinitis—Metformin—metabolic syndrome X	0.00334	0.00993	CcSEcCtD
Lansoprazole—Hepatitis—Metformin—metabolic syndrome X	0.00333	0.00991	CcSEcCtD
Lansoprazole—Hypoaesthesia—Metformin—metabolic syndrome X	0.00331	0.00986	CcSEcCtD
Lansoprazole—Oedema peripheral—Metformin—metabolic syndrome X	0.00328	0.00976	CcSEcCtD
Lansoprazole—Connective tissue disorder—Metformin—metabolic syndrome X	0.00327	0.00974	CcSEcCtD
Lansoprazole—Eye disorder—Metformin—metabolic syndrome X	0.00311	0.00926	CcSEcCtD
Lansoprazole—Cardiac disorder—Metformin—metabolic syndrome X	0.00309	0.0092	CcSEcCtD
Lansoprazole—Angiopathy—Metformin—metabolic syndrome X	0.00302	0.00899	CcSEcCtD
Lansoprazole—Immune system disorder—Metformin—metabolic syndrome X	0.00301	0.00895	CcSEcCtD
Lansoprazole—Mediastinal disorder—Metformin—metabolic syndrome X	0.003	0.00893	CcSEcCtD
Lansoprazole—Chills—Metformin—metabolic syndrome X	0.00299	0.00889	CcSEcCtD
Lansoprazole—CYP1B1—cardiovascular system—metabolic syndrome X	0.00296	0.0305	CbGeAlD
Lansoprazole—Malnutrition—Metformin—metabolic syndrome X	0.0029	0.00862	CcSEcCtD
Lansoprazole—Erythema—Metformin—metabolic syndrome X	0.0029	0.00862	CcSEcCtD
Lansoprazole—CYP1B1—kidney—metabolic syndrome X	0.00289	0.0299	CbGeAlD
Lansoprazole—Flatulence—Metformin—metabolic syndrome X	0.00286	0.0085	CcSEcCtD
Lansoprazole—Dysgeusia—Metformin—metabolic syndrome X	0.00284	0.00845	CcSEcCtD
Lansoprazole—Muscle spasms—Metformin—metabolic syndrome X	0.00279	0.00829	CcSEcCtD
Lansoprazole—Vision blurred—Metformin—metabolic syndrome X	0.00273	0.00813	CcSEcCtD
Lansoprazole—Tremor—Metformin—metabolic syndrome X	0.00272	0.00808	CcSEcCtD
Lansoprazole—Ill-defined disorder—Metformin—metabolic syndrome X	0.00269	0.008	CcSEcCtD
Lansoprazole—Malaise—Metformin—metabolic syndrome X	0.00262	0.00778	CcSEcCtD
Lansoprazole—CYP1B1—adipose tissue—metabolic syndrome X	0.00261	0.0269	CbGeAlD
Lansoprazole—Syncope—Metformin—metabolic syndrome X	0.0026	0.00773	CcSEcCtD
Lansoprazole—Palpitations—Metformin—metabolic syndrome X	0.00256	0.00762	CcSEcCtD
Lansoprazole—Loss of consciousness—Metformin—metabolic syndrome X	0.00255	0.00758	CcSEcCtD
Lansoprazole—Hypertension—Metformin—metabolic syndrome X	0.0025	0.00745	CcSEcCtD
Lansoprazole—Myalgia—Metformin—metabolic syndrome X	0.00247	0.00734	CcSEcCtD
Lansoprazole—Chest pain—Metformin—metabolic syndrome X	0.00247	0.00734	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00245	0.00729	CcSEcCtD
Lansoprazole—Discomfort—Metformin—metabolic syndrome X	0.00244	0.00725	CcSEcCtD
Lansoprazole—ABCB1—blood vessel—metabolic syndrome X	0.00243	0.0251	CbGeAlD
Lansoprazole—Oedema—Metformin—metabolic syndrome X	0.00237	0.00704	CcSEcCtD
Lansoprazole—Infection—Metformin—metabolic syndrome X	0.00235	0.00699	CcSEcCtD
Lansoprazole—Shock—Metformin—metabolic syndrome X	0.00233	0.00693	CcSEcCtD
Lansoprazole—Nervous system disorder—Metformin—metabolic syndrome X	0.00232	0.0069	CcSEcCtD
Lansoprazole—Thrombocytopenia—Metformin—metabolic syndrome X	0.00232	0.00689	CcSEcCtD
Lansoprazole—Skin disorder—Metformin—metabolic syndrome X	0.0023	0.00684	CcSEcCtD
Lansoprazole—Hyperhidrosis—Metformin—metabolic syndrome X	0.00229	0.0068	CcSEcCtD
Lansoprazole—Anorexia—Metformin—metabolic syndrome X	0.00226	0.00671	CcSEcCtD
Lansoprazole—CYP2C8—kidney—metabolic syndrome X	0.00222	0.0229	CbGeAlD
Lansoprazole—Hypotension—Metformin—metabolic syndrome X	0.00221	0.00658	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00216	0.00641	CcSEcCtD
Lansoprazole—Paraesthesia—Metformin—metabolic syndrome X	0.00213	0.00632	CcSEcCtD
Lansoprazole—Dyspnoea—Metformin—metabolic syndrome X	0.00211	0.00628	CcSEcCtD
Lansoprazole—Somnolence—Metformin—metabolic syndrome X	0.0021	0.00626	CcSEcCtD
Lansoprazole—Dyspepsia—Metformin—metabolic syndrome X	0.00208	0.0062	CcSEcCtD
Lansoprazole—Decreased appetite—Metformin—metabolic syndrome X	0.00206	0.00612	CcSEcCtD
Lansoprazole—CYP1A1—kidney—metabolic syndrome X	0.00205	0.0211	CbGeAlD
Lansoprazole—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00204	0.00608	CcSEcCtD
Lansoprazole—Fatigue—Metformin—metabolic syndrome X	0.00204	0.00607	CcSEcCtD
Lansoprazole—Constipation—Metformin—metabolic syndrome X	0.00202	0.00602	CcSEcCtD
Lansoprazole—CYP2C9—cardiovascular system—metabolic syndrome X	0.00201	0.0208	CbGeAlD
Lansoprazole—Feeling abnormal—Metformin—metabolic syndrome X	0.00195	0.0058	CcSEcCtD
Lansoprazole—ABCG2—adipose tissue—metabolic syndrome X	0.00194	0.0201	CbGeAlD
Lansoprazole—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00194	0.00576	CcSEcCtD
Lansoprazole—Urticaria—Metformin—metabolic syndrome X	0.00188	0.00559	CcSEcCtD
Lansoprazole—Abdominal pain—Metformin—metabolic syndrome X	0.00187	0.00556	CcSEcCtD
Lansoprazole—CYP1A1—adipose tissue—metabolic syndrome X	0.00184	0.019	CbGeAlD
Lansoprazole—CYP1B1—liver—metabolic syndrome X	0.00183	0.0189	CbGeAlD
Lansoprazole—Asthenia—Metformin—metabolic syndrome X	0.0017	0.00505	CcSEcCtD
Lansoprazole—Pruritus—Metformin—metabolic syndrome X	0.00167	0.00498	CcSEcCtD
Lansoprazole—Diarrhoea—Metformin—metabolic syndrome X	0.00162	0.00482	CcSEcCtD
Lansoprazole—CYP2C19—liver—metabolic syndrome X	0.0016	0.0166	CbGeAlD
Lansoprazole—Dizziness—Metformin—metabolic syndrome X	0.00157	0.00465	CcSEcCtD
Lansoprazole—Vomiting—Metformin—metabolic syndrome X	0.0015	0.00448	CcSEcCtD
Lansoprazole—CYP3A4—kidney—metabolic syndrome X	0.0015	0.0155	CbGeAlD
Lansoprazole—Rash—Metformin—metabolic syndrome X	0.00149	0.00444	CcSEcCtD
Lansoprazole—Dermatitis—Metformin—metabolic syndrome X	0.00149	0.00443	CcSEcCtD
Lansoprazole—Headache—Metformin—metabolic syndrome X	0.00148	0.00441	CcSEcCtD
Lansoprazole—CYP2D6—kidney—metabolic syndrome X	0.00148	0.0153	CbGeAlD
Lansoprazole—Nausea—Metformin—metabolic syndrome X	0.00141	0.00418	CcSEcCtD
Lansoprazole—CYP2C8—liver—metabolic syndrome X	0.0014	0.0145	CbGeAlD
Lansoprazole—ABCG2—liver—metabolic syndrome X	0.00136	0.0141	CbGeAlD
Lansoprazole—CYP1A2—liver—metabolic syndrome X	0.00131	0.0135	CbGeAlD
Lansoprazole—CYP1A1—liver—metabolic syndrome X	0.00129	0.0134	CbGeAlD
Lansoprazole—CYP2C9—liver—metabolic syndrome X	0.00124	0.0129	CbGeAlD
Lansoprazole—ABCB1—cardiovascular system—metabolic syndrome X	0.00109	0.0112	CbGeAlD
Lansoprazole—ABCB1—kidney—metabolic syndrome X	0.00106	0.011	CbGeAlD
Lansoprazole—ABCB1—adipose tissue—metabolic syndrome X	0.000958	0.00989	CbGeAlD
Lansoprazole—CYP3A4—liver—metabolic syndrome X	0.000949	0.0098	CbGeAlD
Lansoprazole—CYP2D6—liver—metabolic syndrome X	0.000934	0.00964	CbGeAlD
Lansoprazole—ABCB1—liver—metabolic syndrome X	0.000672	0.00694	CbGeAlD
Lansoprazole—CYP1B1—Metabolism—APOA1—metabolic syndrome X	6.5e-05	0.000115	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	6.48e-05	0.000114	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GCK—metabolic syndrome X	6.48e-05	0.000114	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—LIPC—metabolic syndrome X	6.48e-05	0.000114	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOC3—metabolic syndrome X	6.44e-05	0.000114	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NAMPT—metabolic syndrome X	6.37e-05	0.000112	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GCKR—metabolic syndrome X	6.36e-05	0.000112	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—LPA—metabolic syndrome X	6.36e-05	0.000112	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HMGCR—metabolic syndrome X	6.34e-05	0.000112	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GOT2—metabolic syndrome X	6.34e-05	0.000112	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—LIPC—metabolic syndrome X	6.33e-05	0.000112	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GCK—metabolic syndrome X	6.33e-05	0.000112	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PPARA—metabolic syndrome X	6.31e-05	0.000111	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOC3—metabolic syndrome X	6.29e-05	0.000111	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CETP—metabolic syndrome X	6.25e-05	0.00011	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	6.23e-05	0.00011	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ABCA1—metabolic syndrome X	6.16e-05	0.000109	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—SLC2A4—metabolic syndrome X	6.16e-05	0.000109	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PLA2G6—metabolic syndrome X	6.16e-05	0.000109	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTGS2—metabolic syndrome X	6.11e-05	0.000108	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	6.11e-05	0.000108	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AGT—metabolic syndrome X	6.11e-05	0.000108	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CETP—metabolic syndrome X	6.1e-05	0.000108	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOA5—metabolic syndrome X	6.09e-05	0.000107	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—FABP4—metabolic syndrome X	6.09e-05	0.000107	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	6e-05	0.000106	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	5.99e-05	0.000106	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—SCARB1—metabolic syndrome X	5.99e-05	0.000106	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—APOE—metabolic syndrome X	5.98e-05	0.000106	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GGT1—metabolic syndrome X	5.97e-05	0.000105	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GOT1—metabolic syndrome X	5.97e-05	0.000105	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—LIPC—metabolic syndrome X	5.96e-05	0.000105	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GCK—metabolic syndrome X	5.96e-05	0.000105	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NAMPT—metabolic syndrome X	5.95e-05	0.000105	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOC3—metabolic syndrome X	5.92e-05	0.000104	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	5.92e-05	0.000104	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—APOA1—metabolic syndrome X	5.92e-05	0.000104	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	5.91e-05	0.000104	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GCK—metabolic syndrome X	5.91e-05	0.000104	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—LIPC—metabolic syndrome X	5.91e-05	0.000104	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOC3—metabolic syndrome X	5.87e-05	0.000104	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—SCARB1—metabolic syndrome X	5.84e-05	0.000103	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	5.83e-05	0.000103	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—SREBF1—metabolic syndrome X	5.81e-05	0.000103	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	5.8e-05	0.000102	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	5.77e-05	0.000102	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CETP—metabolic syndrome X	5.75e-05	0.000101	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	5.73e-05	0.000101	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PPARG—metabolic syndrome X	5.73e-05	0.000101	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	5.71e-05	0.000101	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CETP—metabolic syndrome X	5.7e-05	0.000101	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—SREBF1—metabolic syndrome X	5.67e-05	0.0001	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	5.67e-05	9.99e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HMGCR—metabolic syndrome X	5.65e-05	9.97e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GOT2—metabolic syndrome X	5.65e-05	9.97e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ABCA1—metabolic syndrome X	5.65e-05	9.96e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—SLC2A4—metabolic syndrome X	5.65e-05	9.96e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—INS—metabolic syndrome X	5.62e-05	9.91e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GOT2—metabolic syndrome X	5.52e-05	9.74e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HMGCR—metabolic syndrome X	5.52e-05	9.74e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	5.51e-05	9.71e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GGT1—metabolic syndrome X	5.47e-05	9.65e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GOT1—metabolic syndrome X	5.47e-05	9.65e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	5.46e-05	9.63e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	5.41e-05	9.54e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	5.35e-05	9.43e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	5.32e-05	9.38e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	5.3e-05	9.35e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PPARG—metabolic syndrome X	5.21e-05	9.19e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	5.2e-05	9.17e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GOT2—metabolic syndrome X	5.2e-05	9.17e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	5.16e-05	9.09e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GOT2—metabolic syndrome X	5.16e-05	9.09e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ALB—metabolic syndrome X	5.15e-05	9.09e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—G6PD—metabolic syndrome X	5.14e-05	9.07e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—INS—metabolic syndrome X	5.11e-05	9.02e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	5.1e-05	9e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	5.08e-05	8.96e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOB—metabolic syndrome X	5.06e-05	8.93e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	5.05e-05	8.91e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—LIPC—metabolic syndrome X	5.05e-05	8.91e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GCK—metabolic syndrome X	5.05e-05	8.91e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	5.04e-05	8.89e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	5.04e-05	8.89e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	5.02e-05	8.85e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOC3—metabolic syndrome X	5.02e-05	8.85e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—NOS3—metabolic syndrome X	4.93e-05	8.69e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PLA2G4A—metabolic syndrome X	4.92e-05	8.68e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ABCA1—metabolic syndrome X	4.92e-05	8.68e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	4.92e-05	8.68e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LPA—metabolic syndrome X	4.91e-05	8.65e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GCKR—metabolic syndrome X	4.91e-05	8.65e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GOT1—metabolic syndrome X	4.88e-05	8.61e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GGT1—metabolic syndrome X	4.88e-05	8.61e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CETP—metabolic syndrome X	4.87e-05	8.59e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—LPL—metabolic syndrome X	4.83e-05	8.52e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GGT1—metabolic syndrome X	4.76e-05	8.4e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GOT1—metabolic syndrome X	4.76e-05	8.4e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	4.75e-05	8.38e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOA5—metabolic syndrome X	4.7e-05	8.3e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ALB—metabolic syndrome X	4.69e-05	8.27e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	4.67e-05	8.23e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	4.65e-05	8.2e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOB—metabolic syndrome X	4.64e-05	8.19e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	4.64e-05	8.18e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	4.64e-05	8.18e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	4.6e-05	8.11e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	4.6e-05	8.11e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CD36—metabolic syndrome X	4.59e-05	8.1e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	4.54e-05	8.01e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	4.53e-05	7.99e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PLA2G4A—metabolic syndrome X	4.51e-05	7.96e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—metabolic syndrome X	4.51e-05	7.95e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GOT1—metabolic syndrome X	4.49e-05	7.92e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GGT1—metabolic syndrome X	4.49e-05	7.92e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—NOS3—metabolic syndrome X	4.48e-05	7.91e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GGT1—metabolic syndrome X	4.45e-05	7.85e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GOT1—metabolic syndrome X	4.45e-05	7.85e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—LPL—metabolic syndrome X	4.43e-05	7.82e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	4.41e-05	7.77e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GOT2—metabolic syndrome X	4.41e-05	7.77e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	4.37e-05	7.71e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARA—metabolic syndrome X	4.27e-05	7.53e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CD36—metabolic syndrome X	4.21e-05	7.43e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOB—metabolic syndrome X	4.14e-05	7.31e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AGT—metabolic syndrome X	4.13e-05	7.29e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—metabolic syndrome X	4.1e-05	7.23e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOE—metabolic syndrome X	4.05e-05	7.15e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOB—metabolic syndrome X	4.04e-05	7.13e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	4.03e-05	7.11e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOA1—metabolic syndrome X	4e-05	7.06e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	3.97e-05	7.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—LPL—metabolic syndrome X	3.95e-05	6.98e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	3.93e-05	6.94e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	3.93e-05	6.93e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	3.93e-05	6.93e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	3.92e-05	6.92e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARA—metabolic syndrome X	3.91e-05	6.9e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LIPC—metabolic syndrome X	3.9e-05	6.87e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GCK—metabolic syndrome X	3.9e-05	6.87e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOC3—metabolic syndrome X	3.87e-05	6.83e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—LPL—metabolic syndrome X	3.86e-05	6.81e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOB—metabolic syndrome X	3.81e-05	6.72e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GGT1—metabolic syndrome X	3.8e-05	6.71e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GOT1—metabolic syndrome X	3.8e-05	6.71e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AGT—metabolic syndrome X	3.79e-05	6.69e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOB—metabolic syndrome X	3.78e-05	6.66e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CETP—metabolic syndrome X	3.76e-05	6.63e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CD36—metabolic syndrome X	3.76e-05	6.63e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOE—metabolic syndrome X	3.71e-05	6.55e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	3.71e-05	6.54e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	3.67e-05	6.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOA1—metabolic syndrome X	3.67e-05	6.48e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CD36—metabolic syndrome X	3.67e-05	6.47e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—LPL—metabolic syndrome X	3.64e-05	6.42e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—LPL—metabolic syndrome X	3.61e-05	6.36e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	3.6e-05	6.35e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARG—metabolic syndrome X	3.53e-05	6.22e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—AKT1—metabolic syndrome X	3.52e-05	6.2e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	3.5e-05	6.17e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARA—metabolic syndrome X	3.49e-05	6.16e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—INS—metabolic syndrome X	3.46e-05	6.1e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CD36—metabolic syndrome X	3.46e-05	6.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CD36—metabolic syndrome X	3.43e-05	6.04e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARA—metabolic syndrome X	3.41e-05	6.01e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	3.4e-05	6e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GOT2—metabolic syndrome X	3.4e-05	6e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AGT—metabolic syndrome X	3.38e-05	5.97e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOE—metabolic syndrome X	3.32e-05	5.85e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AGT—metabolic syndrome X	3.3e-05	5.82e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOA1—metabolic syndrome X	3.28e-05	5.78e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOE—metabolic syndrome X	3.24e-05	5.71e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARG—metabolic syndrome X	3.24e-05	5.71e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOB—metabolic syndrome X	3.23e-05	5.69e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARA—metabolic syndrome X	3.21e-05	5.67e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOA1—metabolic syndrome X	3.2e-05	5.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARA—metabolic syndrome X	3.19e-05	5.62e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—INS—metabolic syndrome X	3.17e-05	5.6e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ALB—metabolic syndrome X	3.17e-05	5.6e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	3.14e-05	5.54e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AGT—metabolic syndrome X	3.11e-05	5.49e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AGT—metabolic syndrome X	3.09e-05	5.44e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—LPL—metabolic syndrome X	3.08e-05	5.44e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—AKT1—metabolic syndrome X	3.07e-05	5.42e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOE—metabolic syndrome X	3.05e-05	5.38e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—NOS3—metabolic syndrome X	3.04e-05	5.35e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	3.03e-05	5.35e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	3.03e-05	5.35e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOE—metabolic syndrome X	3.02e-05	5.33e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOA1—metabolic syndrome X	3.01e-05	5.32e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOA1—metabolic syndrome X	2.99e-05	5.27e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GGT1—metabolic syndrome X	2.94e-05	5.18e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GOT1—metabolic syndrome X	2.94e-05	5.18e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CD36—metabolic syndrome X	2.93e-05	5.16e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ALB—metabolic syndrome X	2.91e-05	5.13e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARG—metabolic syndrome X	2.89e-05	5.09e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—INS—metabolic syndrome X	2.83e-05	5e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARG—metabolic syndrome X	2.82e-05	4.97e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NOS3—metabolic syndrome X	2.78e-05	4.91e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—metabolic syndrome X	2.78e-05	4.9e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—INS—metabolic syndrome X	2.76e-05	4.88e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARA—metabolic syndrome X	2.72e-05	4.8e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARG—metabolic syndrome X	2.66e-05	4.68e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AGT—metabolic syndrome X	2.64e-05	4.65e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARG—metabolic syndrome X	2.63e-05	4.64e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—INS—metabolic syndrome X	2.6e-05	4.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALB—metabolic syndrome X	2.6e-05	4.58e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOE—metabolic syndrome X	2.58e-05	4.56e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—INS—metabolic syndrome X	2.58e-05	4.55e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOA1—metabolic syndrome X	2.55e-05	4.5e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—metabolic syndrome X	2.54e-05	4.49e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALB—metabolic syndrome X	2.53e-05	4.47e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOB—metabolic syndrome X	2.49e-05	4.39e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NOS3—metabolic syndrome X	2.48e-05	4.38e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NOS3—metabolic syndrome X	2.42e-05	4.28e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	2.42e-05	4.27e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALB—metabolic syndrome X	2.39e-05	4.21e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LPL—metabolic syndrome X	2.38e-05	4.19e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALB—metabolic syndrome X	2.37e-05	4.18e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NOS3—metabolic syndrome X	2.28e-05	4.03e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	2.27e-05	4.01e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—AKT1—metabolic syndrome X	2.27e-05	4e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NOS3—metabolic syndrome X	2.26e-05	3.99e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CD36—metabolic syndrome X	2.26e-05	3.99e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARG—metabolic syndrome X	2.25e-05	3.97e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—metabolic syndrome X	2.22e-05	3.91e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—INS—metabolic syndrome X	2.21e-05	3.89e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARA—metabolic syndrome X	2.1e-05	3.71e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	2.09e-05	3.69e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	2.07e-05	3.65e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AKT1—metabolic syndrome X	2.06e-05	3.64e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AGT—metabolic syndrome X	2.03e-05	3.59e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALB—metabolic syndrome X	2.02e-05	3.57e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOE—metabolic syndrome X	1.99e-05	3.52e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOA1—metabolic syndrome X	1.97e-05	3.48e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NOS3—metabolic syndrome X	1.94e-05	3.41e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	1.77e-05	3.12e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARG—metabolic syndrome X	1.74e-05	3.06e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—INS—metabolic syndrome X	1.7e-05	3e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALB—metabolic syndrome X	1.56e-05	2.75e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NOS3—metabolic syndrome X	1.49e-05	2.63e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AKT1—metabolic syndrome X	1.4e-05	2.46e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	1.37e-05	2.41e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AKT1—metabolic syndrome X	1.28e-05	2.26e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AKT1—metabolic syndrome X	1.14e-05	2.01e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.11e-05	1.97e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AKT1—metabolic syndrome X	1.05e-05	1.85e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AKT1—metabolic syndrome X	1.04e-05	1.84e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AKT1—metabolic syndrome X	8.9e-06	1.57e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKT1—metabolic syndrome X	6.87e-06	1.21e-05	CbGpPWpGaD
